Several peptides show different effects on food intake between broiler and layer chicks. For example, the central administration of β-melanocyte-stimulating hormone decreased food intake in layer chicks but not in broiler chicks. The central administration of agouti-related protein increased food intake in layer chicks but not in broiler chicks. We previously reported that glucagon and neuromedin U (NMU) suppress food intake in layer chicks when administered centrally. However, the effects of these peptides on food intake in broiler chicks have not been examined. In the present study, we thus examined whether these peptides also show anorexigenic effects in broiler chicks. The intracerebroventricular administration of glucagon significantly suppressed food intake and increased plasma glucose concentration in broiler chicks. The hyperglycemic effect of glucagon had been shown in layer chicks in our previous studies. Intracerebroventricular administration of NMU significantly suppressed food intake and induced wingflapping behavior in broiler chicks as well as in layer chicks. All our findings demonstrate that glucagon and NMU function as anorxigenic peptides in both broiler and layer chicks.
Introduction
Modern broiler chicks eat more food than layer chicks (Saneyasu et al., 2011) , and their overconsumption of food can lead to the excessive accumulation of visceral fat (Richards and Proszkowiec-Weglarz, 2007; Wang et al., 2010) . This accumulation is regarded as an animal byproduct or as waste. Furthermore, a series of metabolic disorders also occur in chickens as well as in humans (Julian, 2005) . Thus, the regulatory mechanisms of food intake in poultry have been extensively studied in recent decades (Kuenzel, 1994; Furuse, 2002; Bungo et al., 2011) .
Growing evidence indicates that several peptides show different effects on food intake between broiler and layer chicks. For example, central administration of insulin decreased food intake in layer chicks but not in broiler chicks . This difference may partly be associated with the differences in feeding regulation between layer and broiler chicks. We previously showed that the central administration of β-melanocyte-stimulating hormone (β-MSH) decreased food intake in layer chicks but not in broiler chicks, suggesting that the absence of the anorexigenic effect of β-MSH might be related to the increased food intake in broiler chicks (Honda et al., 2012b) . Central administration of agouti-related protein increased food intake in layer chicks but not in broiler chicks, suggesting that the anorexigenic effect of endogenous α-MSH may not be important in broiler chicks at least in the neonatal stage (Tachibana et al., 2001) . Thus, the different effect of peptides on food intake between broiler and layer chicks may be the cause of hyperphagia in broiler chicks.
We previously showed that the central administration of glucagon suppresses food intake in layer chicks and suggested that corticotropin-releasing factor (CRF) -and/or hyperglycemia-mediated pathways are involved in the anorexigenic action of glucagon in layer chicks (Honda et al., , 2012a . We also showed that the central administration of neuromedin U (NMU) suppresses food intake and induces wing-flapping behavior in layer chicks . The anorexigenic effects of glucagon and NMU were also conserved in mammals (Hanada et al., 2004; Kurose et al., 2009; Inokuchi et al., 1984) . However, the effects of these peptides on food intake have not yet been examined in broiler chicks.
In the present study, we examined the central effects of glucagon and NMU in broiler chicks. The results suggest that glucagon and NMU suppress food intake in a similar manner in both broiler and layer chicks.
Materials and Methods

Animals and Peptides
Day-old male broiler chicks (Ross 308) and layer chicks (White Leghorn) were purchased from a local hatchery (Ishii Co., Ltd., Tokushima, Japan and Japan Layer K.K., Gifu, Japan, respectively). They were given free access to water and a commercial chick starter diet (Nippon Formula Feed Mfg. Co., Ltd., Kanagawa, Japan). Room temperature was maintained at 32℃±2℃. This study was approved by the Institutional Animal Care and Use Committee (permission number: 24-03-06) and carried out according to the Kobe University Animal Experimentation Regulation. Chicken glucagon was purchased from Peptide Institute, Inc. (Osaka, Japan), as a custom peptide. Rat NMU was also purchased from Peptide Institute, Inc. (Osaka, Japan).
Experiment 1: Effects of Central Administration of Glucagon on Food Intake and Plasma Glucose Concentration in Broiler Chicks
Thirty 4-day-old broiler chicks were weighed and allocated to three groups based on body weight (10 birds in each group). Chicken glucagon was dissolved in a saline solution containing 0.1% (w/v) Evans Blue. The peptide (0, 0.3, or 1 μg) was intracerebroventricularly administered according to the method of Davis et al. (1979) at a volume of 10 μL after 3 h of fasting, as well as in the previous study . Food intake was measured at 30, 60 and 120 min after administration. At the end of the experiment, the chicks were sacrificed by decapitation, and their blood was collected. EDTA (1 mg/ml blood) was used as the anticoagulant. Plasma was separated by centrifugation at 3,000×g for 10 min at 4℃. Plasma glucose concentration was determined by the Somogyi-Nelson method (Somogyi, 1952) . Verification of injection was performed by observation of the presence of Evans Blue dye in the lateral ventricle.
Experiment 2: Effects of Central Administration of Neuromedin U on Food Intake, Wing-flapping Behavior, and Plasma Glucose Concentration in Broiler and Layer Chicks
Thirty 4-day-old broiler chicks and thirty 8-day-old layer chicks were weighed and allocated to three groups based on body weight (10 birds in each group). NMU (0, 0.2, or 2 μg) was intracerebroventricularly administered after 3 h of fasting as described above. According to the method of Tachibana et al. (2004) , the behaviors of the 0 and 2 μg NMU groups were video-recorded for 10 min after the administration using a video camera in order to investigate the chicks' posture while they were contained in a plastic cage (191×266×163 mm) . At the end of the experiment, the chicks were sacrificed by decapitation and their blood was collected. Plasma glucose concentration was determined as described above. Verification of injection was performed by observation of the presence of Evans Blue dye in the lateral ventricle.
Experiment 3: Real-time PCR Analysis of the mRNA Levels of Proglucagon and Neuromedin U in the Brain in Broiler and Layer Chicks
Six 8-day-old broiler and layer chicks were sacrificed by decapitation and the hypothalamus and medulla oblongata were excised, immediately frozen by liquid nitrogen and stored at −80℃. Total RNA was extracted from the frozen tissues using the Sepazol-RNA I (Nacalai Tesque, Inc., Kyoto, Japan). First-strand complementary DNA (cDNA) was synthesized from total RNA using a ReverTra Ace ® qPCR RT Master Mix with gDNA Remover (Toyobo Co. Ltd, Osaka, Japan). Complementary DNA of NMU (GenBank accession no. NM_001277921) was amplified with the following primers: sense, 5′ -TTG GAG GCA GAG CAG GAA CT-3′ ; antisense, 5′ -AGG CAG AAC AGG CAT CGT CTA-3′ . NMU primers were purchased from FASMAC Co., Ltd. (Kanagawa, Japan). Complementary DNA of proglucagon was amplified with the primers as previously described (Honda et al., 2015b) . As an internal standard, cDNA of ribosomal protein S17 (RPS17) was also amplified with the primers as previously described (Honda et al., 2015b) . THUNDERBIRD TM SYBR ® qPCR Mix was purchased from Toyobo Co. Ltd. (Osaka, Japan), and mRNA expression was quantified in duplicate using the Applied Biosystems 7300 Real-Time PCR system according to the supplier's recommendations.
Statistical Analysis
Data from Experiment 1 were analyzed by the TukeyKramer test. Data of food intake from Experiment 2 were analyzed by the Tukey-Kramer test. Data of wing-flapping behavior from Experiment 2 were analyzed by Student's ttest. Data from Experiment 3 were analyzed by Student's ttest. All statistical analyses were performed using a commercial package (StatView version 5, SAS Institute, Cary, NC, USA).
Results
We previously showed that the central administration of 0.1-1 μg of glucagon in layer chicks significantly suppressed food intake in a dose-dependent manner . In addition, central administration of 0.3-1 μg of glucagon in layer chicks significantly increased plasma glucose concentration . On the basis of these results, doses from 0.3 to 1 μg were used in Experiment 1. Intracerebroventricular administration of glucagon significantly suppressed food intake in broiler chicks (Fig. 1) . In addition, significant increases of plasma glucose concentration were observed in the 0.3 and 1 μg groups (Fig. 2) .
We previously showed that the central administration of 0.1-10 μg of NMU in layer chicks significantly suppressed food intake, and the number with NMU-induced wingflapping was highest in the 1 μg NMU group. However, the anorexigenic effect in the 1 μg NMU group did not continue until 120 min after administration . On the basis of this result, doses from 2 to 10 μg were used in Experiment 2. Intracerebroventricular administration of NMU in broiler and layer chicks significantly suppressed food intake (Fig. 3) and induced wing flapping behavior (Fig. 4) . Significant decrease of plasma glucose concentration was observed in the 10 μg group in layer chicks (Fig. 5) .
In mammals, it is assumed that all axonal terminal fields in Honda et al.: Glucagon and Neuromedin U in Chicks the central nervous system containing proglucagon-derived peptides originate in the nucleus solitary tract (NTS) in the medulla oblongata (Vrang and Larsen, 2010) . NMU is mainly produced in the arcuate nucleus of the hypothalamus (Howard et al., 2000) . Ivanov et al. (2004) reported that NMU-expressing neurons within the NTS may mediate some peripheral satiety signaling. Therefore, we analyzed the mRNA levels of proglucagon in medulla oblongata and the mRNA levels of NMU in medulla oblongata and hypothalamus in broiler and layer chicks and found that there is no significant difference in the mRNA levels of proglucagon and NMU between broiler and layer chicks (Fig. 6 ).
Discussion
There is evidence that different effects of peptides on food intake between broiler and layer chicks may be the cause of hyperphagia in broiler chicks. For example, the anorexigenic effect of β-MSH and insulin was not observed in broiler chicks (Honda et al., 2012b; Shiraishi et al., 2011) . Thus, the aim of this study was to clarify whether glucagon and NMU are involved in hyperphagia in broiler chicks. However, glucagon showed anorexigenic effect in broiler chicks (Fig. 1) . The anorexigenic effect of NMU was clearly shown in broiler and layer chicks (Fig. 1) . In addition, there was no significant difference in the mRNA levels of gluJournal of Poultry Science, 52 (4) cagon and NMU between layer and broiler chicks (Fig. 6) . Therefore, it seems likely that these peptides are not related to hyperphagia in broiler chicks.
We previously showed that the central administration of several anorexigenic peptides significantly decreased food intake and plasma glucose concentration in chicks (Honda et al., 2012a (Honda et al., , 2014a (Honda et al., , b, 2015a . The anorexigenic peptidedecreased plasma glucose would be the result of suppressed food intake because fasting decreases plasma glucose concentration in general. However, the central administration of glucagon increased plasma glucose concentration (Fig. 2) , although food intake was significantly decreased (Fig. 1) . We previously reported the same phenomena in layer chicks . Blood glucose is known to be one of the satiety signals in mammals. It is therefore likely that glucagon suppresses food intake in broiler chicks as well as in layer chicks.
Central administration of NMU significantly decreased plasma glucose concentration in layer chicks but not in broiler chicks (Fig. 2) . The decrease of plasma glucose in layer chicks would be the result of suppressed food intake because the relative food intake of layer chicks (30 min, 8.9 ±1.5 g/kg body weight; 60 min, 10.1±1.9 g/kg body weight; 120 min, 18.7±4.3 g/kg body weight, respectively) was lower than that of broiler chicks (30 min, 16.2±4.8 g/kg body weight; 60 min, 25.6±4.1 g/kg body weight; 120 min, 30.3±4.8 g/kg body weight, respectively) throughout the experimental periods. It is therefore likely that the significant decrease of plasma glucose concentration was not observed in broiler chicks.
Central administration of glucagon suppresses feeding behavior in mammals and chickens (Honda et al., , 2012a Inokuchi et al., 1984) . However, any other behavioral changes were not reported when glucagon was administered centrally in mammals and birds. Therefore, we did not measure behavioral changes in glucagon experiment. In contrast, the central administration of NMU induces behavioral changes in mammals (Wren et al., 2002) and chickens . For example, NMU induces locomotor activity, grooming behavior, and face- Honda et al.: Glucagon and Neuromedin U in Chicks washing behavior in mammals (Wren et al., 2002) . We found that central administration of NMU induces wing flapping behavior in layer chicks . Therefore, we analyzed the effect of central administration of NMU on the wing flapping behavior in broiler and layer chicks and found that NMU induces wing flapping behavior in both types of chicks (Fig. 4) . In mammals, behavioral changes induced by NMU are significantly inhibited by a CRF antagonist (Hanada et al., 2001) . In addition, CRFdeficient mice did not show an increase of locomotor activity after NMU administration (Hanada et al., 2001 ). All of this evidence suggests that NMU-induced behavioral changes are mediated by CRF in mammals. However, the central administration of CRF in chicks does not induce wingflapping behavior (Tachibana et al., 2004) . We also confirmed that NMU-induced wing-flapping behavior can be suppressed by the coadministration of CRF in chicks (unpublished data). It seems likely that NMU-induced wingflapping behavior is not mediated by CRF in chicks.
The central administration of mesotocin or vasotocin, nonmammalian homologues of mammalian oxytocin or vasopressin, respectively, induces wing-flapping behavior and suppresses food intake in layer chicks (Tachibana et al., 2004; Masunari et al., 2013) . In mammals, NMU induces Fos-like immunoreactivity in oxytocin-and/or vasopressincontaining neurons in the hypothalamus (Niimi et al., 2001; Ozaki et al., 2002) . We previously showed that the central administration of NMU increased the mRNA level of vasotocin in the hypothalamus of layer chicks . In the present study, NMU suppressed food intake (Fig. 3) and induced wing-flapping behavior (Fig. 4) in both layer and broiler chicks. These findings raise the possibility that vasotocin and/or mesotocin are involved in the inhibitory mechanisms of NMU for feeding in chicks. Further studies will be required to address this possibility.
Central administration of glucagon significantly increased hypothlamic CRF expression and plasma corticosterone concentraton in layer chicks, suggesting that CRF is a downstream mediator of the glucagon-induced anorexigenic pathway (Honda et al., 2012a) . Also, central administration of NMU significantly increased hypothlamic CRF expression in layer chicks, suggesting that CRF might be a downstream mediator of the NMU-induced anorexigenic pathway . In the present study, glucagon and NMU suppresses food intake in broiler chicks as well as in layer chicks. Threfore, it is possible that CRF acts as a downstream mediator of the glucagon-and NMU-induced anorexigenic pathway in broiler chick. Further study is required to examine the effects of glucagon and NMU on the hypothalamic CRF expression and plasma corticosterone concentration in broiler chicks.
In conclusion, the intracerebroventricular administration of glucagon and NMU significantly decreased food intake in broiler chicks. Glucagon increased plasma glucose concentration, and NMU induced wing-flapping behavior. These effects have been shown in layer chicks. Our findings demonstrate that glucagon and NMU suppress food intake in both broiler and layer chicks.
